Delta Crystallon BV
United States of America
Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Safety and Dose-finding Study of DC-TAB in Healthy Subjects
Phase 1
Completed
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2015-05-13
- Last Posted Date
- 2015-05-13
- Lead Sponsor
- Delta Crystallon BV
- Target Recruit Count
- 76
- Registration Number
- NCT02442557
- Locations
- 🇳🇱
Kendle International, Utrecht, Netherlands
A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis
Phase 2
Completed
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2015-05-13
- Last Posted Date
- 2015-08-27
- Lead Sponsor
- Delta Crystallon BV
- Target Recruit Count
- 32
- Registration Number
- NCT02442570
- Locations
- 🇧🇬
Sveti Naum Hospital, Sofia, Bulgaria
🇧🇬National Cardiology Hopsital, Sofia, Bulgaria
🇧🇬Tokuda Hospital Sofia, Sofia, Bulgaria
News
No news found